16.05.2018 • NewsAzelisElaine Burridge

Azelis Buys South Korea’s SammiChem

Azelis Acquires South Korea’s SammiChem
Azelis Acquires South Korea’s SammiChem

Luxembourg-based specialty chemicals distributor Azelis is establishing a presence in South Korea following an agreement to buy SammiChem. Financial terms of the deal, which is expected to close during the coming three months, were not revealed.

Located in Seoul, SammiChem distributes personal care ingredients, specializing in cosmetics. SammiChem’s owner and CEO said the deal would open up new doors for the company and ensure its future.

Azelis CEO Hans Joachim Muller noted that a large part of the Asia-Pacific personal care was located in South Korea, which was technologically advanced with a highly skilled, affluent middle class. He commented: “As we have been building a very strong technical expertise in life sciences in Asia Pacific, personal care in particular, this all makes South Korea very attractive for us.”

Laureent Nataf, CEO and president of Azelis Asia Pacific, added that the acquisition will allow the distributor to create a solid platform for the region and enable further growth with its principal suppliers.

Azelis is majority owned by UK-based private equity group Apax Partners, which bought the stake from 3i Group in 2015. The distributor has been building up its scale in recent years for a planned initial public offering (IPO), with speculation that this could take place during 2018.

In March, Azelis acquired Moroccan food ingredients distributor, Distralim, a move which it said was part of a strategic focus on Africa.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.